1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with phenyl-n-tert-butylnitrone in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (phenyl-n-tert-butylnitrone) | Trials (phenyl-n-tert-butylnitrone) | Recent Studies (post-2010) (phenyl-n-tert-butylnitrone) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 624 | 3 | 66 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boedker, M; Boetkjaer, A; Cui, JG; Lukiw, WJ; Zhao, Y | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and phenyl-n-tert-butylnitrone
| Article | Year |
|---|---|
Synergism in the repression of COX-2- and TNFalpha-induction in platelet activating factor-stressed human neural cells.
Topics: Anti-Inflammatory Agents; Budesonide; Cell Survival; Cells, Cultured; Cyclic N-Oxides; Cyclooxygenase 2; Dihydropyridines; Dinoprostone; Drug Synergism; Encephalitis; Gene Expression; Humans; Neurons; Oxidative Stress; Platelet Activating Factor; Signal Transduction; Stress, Physiological; Transcriptional Activation; Tumor Necrosis Factor-alpha; Up-Regulation | 2007 |